Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,258
datasets available to search
ShareScore release 0.9.0
Dataset results
1,258 results for “neuroblastoma”
Conceptual Model of Neuroblastoma v2
Open the record for dataset details and reuse information.
Single Cell RNA-seq Profiling of Neuroblastoma and Breast Cancer
<p>This dataset includes seven samples from three patients: neuroblastoma (n = 2) and breast cancer (n = 1). For each neuroblastoma patient, three samples were derived from bone marrow (B), peripheral blood (P), and primary tumor (T). For the breast cancer patient, one sample was derived from peripheral blood.</p>
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
ClinicalTrials.gov study NCT01802138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma
ClinicalTrials.gov study NCT01943097. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
ClinicalTrials.gov study NCT02439788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
ClinicalTrials.gov study NCT02650648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT00450827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
ClinicalTrials.gov study NCT00048386. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
ClinicalTrials.gov study NCT00002748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
ClinicalTrials.gov study NCT06995872. IPD Sharing: YES. Countries: 1. Publications: 0.
Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
ClinicalTrials.gov study NCT00793845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
ClinicalTrials.gov study NCT02298348. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
ClinicalTrials.gov study NCT06071897. IPD Sharing: NO. Countries: 1. Publications: 0.
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
ClinicalTrials.gov study NCT00436696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
ClinicalTrials.gov study NCT06172296. IPD Sharing: YES. Countries: 4. Publications: 0.
Phase 1 Study of BCD-245 in Subjects With Neuroblastoma
ClinicalTrials.gov study NCT05782959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation
ClinicalTrials.gov study NCT00793351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on Sintilimab in Stage IV High Risk Neuroblastoma
ClinicalTrials.gov study NCT04412408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
ClinicalTrials.gov study NCT01241162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
ClinicalTrials.gov study NCT02311621. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.